Company / Profit Margin
Ensysce Biosciences, Inc. Profit Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-153.3%
FY2025
5-year range
-959.3% / -153.3%
FY2022-FY2025
Trend
+67.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -959.3% to -153.3% over the past 2 years.
Based on SEC 10-K filings.
-153.3% in FY2025 with a 3-year CAGR of +672.1%.
Improved from -959.3% to -153.3% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +672.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 67.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -153.3% | +67.8% |
| FY2024 | -476.4% | +50.3% |
| FY2023 | -959.3% | -16.2% |
| FY2022 | -825.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026